Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 1,191,700 | 1,140,900 | 925,000 | 1,128,700 | 1,174,100 |
| Cost of Goods | 296,300 | 281,000 | 238,200 | 265,100 | 286,200 |
| Gross Profit | 895,400 | 859,900 | 686,800 | 863,600 | 887,900 |
| Operating Expenses | 544,300 | 502,100 | 856,700 | 505,600 | 577,300 |
| Operating Income | 351,400 | 357,800 | -169,700 | 358,100 | 310,800 |
| Other Income | 4,700 | 6,500 | 1,500 | 6,400 | 4,700 |
| Pre-tax Income | 356,100 | 364,300 | -168,200 | 364,500 | 315,500 |
| Income Tax | 46,600 | 39,100 | -46,300 | 53,900 | 35,300 |
| Net Income Continuous | 309,500 | 325,200 | -121,900 | 310,600 | 280,200 |
| Net Income | $309,500 | $325,200 | $-121,900 | $310,600 | $280,200 |
| EPS Basic Total Ops | 0.50 | 0.52 | -0.20 | 0.50 | 0.45 |
| EPS Basic Continuous Ops | 0.50 | 0.52 | -0.20 | 0.50 | 0.45 |
| EPS Diluted Total Ops | 0.49 | 0.52 | -0.20 | 0.49 | 0.44 |
| EPS Diluted Continuous Ops | 0.50 | 0.52 | -0.20 | 0.49 | 0.44 |
| EBITDA(a) | $384,000 | $383,400 | $-145,200 | $382,600 | $334,700 |